Literature DB >> 16971014

Genetic and phylogenetic analysis of multi-continent human influenza A(H1N2) reassortant viruses isolated in 2001 through 2003.

M-J Chen1, T La, P Zhao, J S Tam, R Rappaport, S-M Cheng.   

Abstract

Genetic analyses were performed on 228 influenza A(H1) viruses derived from clinical subjects participating in an experimental vaccine trial conducted in 20 countries on four continents between 2001 and 2003. HA1 phylogenetic analysis of these viruses showed multiple clades circulated around the world with regional prevalence patterns. Sixty-five of the A(H1) viruses were identified as A(H1N2), 40 of which were isolated from South Africa. The A(H1) sequences of these viruses cluster with published H1N2 viruses phylogenetically and share with them diagnostic signature V169A and A193T changes. The results also showed for the first time that H1N2 viruses were prominent in South Africa during the 2001-2002 influenza season, accounting for over 90% of the A(H1) cases in our study, and infecting both children (29/31) and the elderly (11/13). Phylogenetic analysis of the 65 H1N2 viruses we identified, in conjunction with the 56 recent H1N2 viruses currently available in the database, provided a comprehensive view of the circulation and evolution of distinct clades of H1N2 viruses in a temporal manner between early 2001 and mid-2003, shortly after the appearance of these recent reassortant viruses in or near year 2000.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16971014     DOI: 10.1016/j.virusres.2006.07.010

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  8 in total

1.  Seasonal H3N2 and 2009 Pandemic H1N1 Influenza A Viruses Reassort Efficiently but Produce Attenuated Progeny.

Authors:  Kara L Phipps; Nicolle Marshall; Hui Tao; Shamika Danzy; Nina Onuoha; John Steel; Anice C Lowen
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

Review 2.  Implications of segment mismatch for influenza A virus evolution.

Authors:  Maria C White; Anice C Lowen
Journal:  J Gen Virol       Date:  2017-12-15       Impact factor: 3.891

3.  Whole-Genome Characterization of a Novel Human Influenza A(H1N2) Virus Variant, Brazil.

Authors:  Paola Cristina Resende; Priscila Silva Born; Aline Rocha Matos; Fernando Couto Motta; Braulia Costa Caetano; Maria do Carmo Debur; Irina Nastassja Riediger; David Brown; Marilda M Siqueira
Journal:  Emerg Infect Dis       Date:  2017-01       Impact factor: 6.883

4.  Novel influenza A(H1N2) seasonal reassortant identified in a patient sample, Sweden, January 2019.

Authors:  Åsa Wiman; Theresa Enkirch; AnnaSara Carnahan; Blenda Böttiger; Tove Samuelsson Hagey; Per Hagstam; Rosmarie Fält; Mia Brytting
Journal:  Euro Surveill       Date:  2019-02

5.  Case of seasonal reassortant A(H1N2) influenza virus infection, the Netherlands, March 2018.

Authors:  Adam Meijer; Corien M Swaan; Martin Voerknecht; Edin Jusic; Sharon van den Brink; Lisa A Wijsman; Bettie Cg Voordouw; Gé A Donker; Jacqueline Sleven; Wendelien W Dorigo-Zetsma; Sanela Svraka; Michiel van Boven; Manon R Haverkate; Aura Timen; Jaap T van Dissel; Marion Pg Koopmans; Theo M Bestebroer; Ron Am Fouchier
Journal:  Euro Surveill       Date:  2018-04

6.  Diversity and Reassortment Rate of Influenza A Viruses in Wild Ducks and Gulls.

Authors:  Yulia Postnikova; Anastasia Treshchalina; Elizaveta Boravleva; Alexandra Gambaryan; Aydar Ishmukhametov; Mikhail Matrosovich; Ron A M Fouchier; Galina Sadykova; Alexey Prilipov; Natalia Lomakina
Journal:  Viruses       Date:  2021-05-27       Impact factor: 5.048

7.  A historical perspective of influenza A(H1N2) virus.

Authors:  Naomi Komadina; Jodie McVernon; Robert Hall; Karin Leder
Journal:  Emerg Infect Dis       Date:  2014-01       Impact factor: 6.883

8.  Natural co-infection of influenza A/H3N2 and A/H1N1pdm09 viruses resulting in a reassortant A/H3N2 virus.

Authors:  Sareth Rith; Savuth Chin; Borann Sar; Phalla Y; Srey Viseth Horm; Sovann Ly; Philippe Buchy; Philippe Dussart; Paul F Horwood
Journal:  J Clin Virol       Date:  2015-11-05       Impact factor: 3.168

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.